LENZ Therapeutics, Inc. (LENZ)
3.16
-0.09
(-2.77%)
USD |
NASDAQ |
Oct 23, 16:00
3.155
0.00 (0.00%)
After-Hours: 20:00
LENZ Therapeutics Total Return Level : 3.361 for Oct. 23, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.361 |
| October 22, 2026 | 3.457 |
| October 21, 2026 | 3.425 |
| October 20, 2026 | 3.393 |
| October 19, 2026 | 3.510 |
| October 16, 2026 | 3.478 |
| October 15, 2026 | 3.797 |
| October 14, 2026 | 3.648 |
| October 13, 2026 | 3.616 |
| October 12, 2026 | 3.840 |
| October 09, 2026 | 3.877 |
| October 08, 2026 | 3.754 |
| October 07, 2026 | 3.850 |
| October 06, 2026 | 4.031 |
| October 05, 2026 | 3.818 |
| October 02, 2026 | 3.808 |
| October 01, 2026 | 4.031 |
| September 30, 2026 | 4.084 |
| September 29, 2026 | 4.105 |
| September 28, 2026 | 4.212 |
| September 25, 2026 | 4.164 |
| September 24, 2026 | 3.956 |
| September 23, 2026 | 3.999 |
| September 22, 2026 | 4.393 |
| September 21, 2026 | 4.339 |
| Date | Value |
|---|---|
| September 18, 2026 | 4.329 |
| September 17, 2026 | 4.393 |
| September 16, 2026 | 4.403 |
| September 15, 2026 | 4.499 |
| September 14, 2026 | 4.754 |
| September 11, 2026 | 4.807 |
| September 10, 2026 | 5.020 |
| September 09, 2026 | 5.222 |
| September 08, 2026 | 5.669 |
| September 04, 2026 | 6.339 |
| September 03, 2026 | 6.201 |
| September 02, 2026 | 6.169 |
| September 01, 2026 | 5.562 |
| August 31, 2026 | 5.541 |
| August 28, 2026 | 5.435 |
| August 27, 2026 | 5.116 |
| August 26, 2026 | 5.084 |
| August 25, 2026 | 4.967 |
| August 24, 2026 | 4.882 |
| August 21, 2026 | 4.978 |
| August 20, 2026 | 4.956 |
| August 19, 2026 | 5.233 |
| August 18, 2026 | 5.073 |
| August 17, 2026 | 5.094 |
| August 14, 2026 | 5.031 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Impact BioMedical, Inc. | 3.60 |
| Enveric Biosciences, Inc. | 1.40 |
| Liquidia Corp. | 42.65 |
| Aquestive Therapeutics, Inc. | 4.00 |
| ANI Pharmaceuticals, Inc. | 72.61 |